List of Tables
Table 1. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Region (2020-2025)
Table 10. Global Molecular Diagnosis of Hereditary Colorectal Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Region (2026-2031)
Table 12. Molecular Diagnosis of Hereditary Colorectal Cancer Market Trends
Table 13. Molecular Diagnosis of Hereditary Colorectal Cancer Market Drivers
Table 14. Molecular Diagnosis of Hereditary Colorectal Cancer Market Challenges
Table 15. Molecular Diagnosis of Hereditary Colorectal Cancer Market Restraints
Table 16. Global Molecular Diagnosis of Hereditary Colorectal Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Players (2020-2025)
Table 18. Global Top Molecular Diagnosis of Hereditary Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Hereditary Colorectal Cancer as of 2024)
Table 19. Ranking of Global Top Molecular Diagnosis of Hereditary Colorectal Cancer Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Molecular Diagnosis of Hereditary Colorectal Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Molecular Diagnosis of Hereditary Colorectal Cancer, Headquarters and Area Served
Table 22. Global Key Players of Molecular Diagnosis of Hereditary Colorectal Cancer, Product and Application
Table 23. Global Key Players of Molecular Diagnosis of Hereditary Colorectal Cancer, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Molecular Diagnosis of Hereditary Colorectal Cancer Revenue Market Share by Type (2020-2025)
Table 27. Global Molecular Diagnosis of Hereditary Colorectal Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Molecular Diagnosis of Hereditary Colorectal Cancer Revenue Market Share by Type (2026-2031)
Table 29. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Molecular Diagnosis of Hereditary Colorectal Cancer Revenue Market Share by Application (2020-2025)
Table 31. Global Molecular Diagnosis of Hereditary Colorectal Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Molecular Diagnosis of Hereditary Colorectal Cancer Revenue Market Share by Application (2026-2031)
Table 33. North America Molecular Diagnosis of Hereditary Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Molecular Diagnosis of Hereditary Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Molecular Diagnosis of Hereditary Colorectal Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Molecular Diagnosis of Hereditary Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Molecular Diagnosis of Hereditary Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 48. Berryoncology Company Details
Table 49. Berryoncology Business Overview
Table 50. Berryoncology Molecular Diagnosis of Hereditary Colorectal Cancer Product
Table 51. Berryoncology Revenue in Molecular Diagnosis of Hereditary Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 52. Berryoncology Recent Development
Table 53. Topgen Company Details
Table 54. Topgen Business Overview
Table 55. Topgen Molecular Diagnosis of Hereditary Colorectal Cancer Product
Table 56. Topgen Revenue in Molecular Diagnosis of Hereditary Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 57. Topgen Recent Development
Table 58. Gene+ Company Details
Table 59. Gene+ Business Overview
Table 60. Gene+ Molecular Diagnosis of Hereditary Colorectal Cancer Product
Table 61. Gene+ Revenue in Molecular Diagnosis of Hereditary Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 62. Gene+ Recent Development
Table 63. Haplox Company Details
Table 64. Haplox Business Overview
Table 65. Haplox Molecular Diagnosis of Hereditary Colorectal Cancer Product
Table 66. Haplox Revenue in Molecular Diagnosis of Hereditary Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 67. Haplox Recent Development
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
Table 71. Authors List of This Report
List of Figures
Figure 1. Molecular Diagnosis of Hereditary Colorectal Cancer Picture
Figure 2. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Molecular Diagnosis of Hereditary Colorectal Cancer Report Years Considered
Figure 14. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Region: 2024 VS 2031
Figure 17. Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Players in 2024
Figure 18. Global Top Molecular Diagnosis of Hereditary Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Hereditary Colorectal Cancer as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Molecular Diagnosis of Hereditary Colorectal Cancer Revenue in 2024
Figure 20. North America Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Country (2020-2031)
Figure 22. United States Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Country (2020-2031)
Figure 26. Germany Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Region (2020-2031)
Figure 34. China Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Country (2020-2031)
Figure 42. Mexico Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Molecular Diagnosis of Hereditary Colorectal Cancer Market Share by Country (2020-2031)
Figure 46. Turkey Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Molecular Diagnosis of Hereditary Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Berryoncology Revenue Growth Rate in Molecular Diagnosis of Hereditary Colorectal Cancer Business (2020-2025)
Figure 50. Topgen Revenue Growth Rate in Molecular Diagnosis of Hereditary Colorectal Cancer Business (2020-2025)
Figure 51. Gene+ Revenue Growth Rate in Molecular Diagnosis of Hereditary Colorectal Cancer Business (2020-2025)
Figure 52. Haplox Revenue Growth Rate in Molecular Diagnosis of Hereditary Colorectal Cancer Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
